Rich Glicklich

CEO

OM1

Dr. Rich Gliklich is CEO of OM1, Inc, an outcomes and technology company focused on using deep clinical data and advanced analytics to measure and predict health outcomes for real world evidence and value-based care. He is also leading a federally funded effort to standardize health outcomes measurement across and within conditions called the Outcomes Measures Framework. Prior to OM1, Rich was founder and CEO of Outcome (acquired in 2011) and an investor in healthcare IT with General Catalyst Partners. Rich is a graduate of Yale University and Harvard Medical School, and a surgeon and professor at Harvard Medical School.

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

Terms & Conditions © 2019 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Videos
  • Asembia Photos
SummitLogo_2020_White.png